Susan Hasty, Publisher
Table of Contents . . . January 16th, 2000
Non-Subscriber - Summaries OnlyRelated Areas: Other Issues in Immunotherapy Weekly | Other Publications
Dermatology (Animal Models) - Advances Reported in Antibody Treatment for Skin Disorders and Inflammation
Allergy Medicine (Animal Models) - CpG Oligodeoxynucleotide Adjuvants Modulate Allergic Response in Mouse Model
Asthma (Treatment) - Compound Decreases Need for Steroids and Reduces Asthma Symptoms
Cancer Immunotherapy - MAGE Gene May Be Immunotherapy Target for Hepatocellular Carcinoma
Cardiopulmonary Bypass (Industry News) - Anti-Inflammatory Drug Reduces Cardiac and Brain Damage in Clinical Trials
Lymphocytic Choriomeningitis (Treatment) - Nitric Oxide Plays Minimal Role in Treatment
AIDS Therapies (Industry News) - Results Show Ampligen Overcomes Viral Resistance
Cancer Immunotherapy (Industry News) - Fusion Protein Developed with Improved Selectivity for Cancer Therapy
Cancer Vaccines - Cancer Vaccine Targets Mutant Genes
Cancer Vaccines (Industry News) - Liposome Technology Shows Promise in Dendritic Cell Therapy for Cancer
Leukemia (Treatment) - Monoclonal Antibody Appears Effective in Patients with Advanced B-Cell Chronic Lymphocytic Leukemia
Non-Hodgkin's Lymphoma (Treatment) - Radioactive Epratuzumab Shows Promising Results in Aggressive Non-Hodkgin's Lymphoma
Rheumatoid Arthritis - Diarrhea Bacteria Could Cure Rheumatoid Arthritis
Cancer Therapies (Industry News) - Collaboration To Develop Monoclonal Antibody for Melanoma, Other Cancers
Graft-vs.-Host Disease (Clinical Trials) - Phase III Clinical Trial Initiated
Industry News - Collaboration Aims To Develop Human Monoclonal Antibody-Based Cancer Therapies
Industry News (Legal Issues) - Class Action Settlement Related to Immune Globulin Therapy Use Announced
Multiple Sclerosis (Industry News) - AstraZeneca Discontinues Development of TCAR Monoclonal Antibody
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.